Birdwatch Note
2022-09-03 16:11:25 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ivermectin still has not been approved to treat COVID-19. A medicine that is potentially approved to treat one thing does not mean it is approved to treat other illnesses. https://www.reuters.com/article/factcheck-ivermectin-covid19/fact-check-website-does-not-prove-government-silently-approved-ivermectin-as-covid-19-treatment-idUSL1N2RN1TO. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Written by 0C91900F7892D8DA899BB85193A8758A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1566041186581757953
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1566096536328617984
- noteId - 1566096536328617984
- participantId - 0C91900F7892D8DA899BB85193A8758A
- noteAuthorParticipantId -
- createdAtMillis - 1662221485585
- tweetId - 1566041186581757953
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - CHALLENGING
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ivermectin still has not been approved to treat COVID-19. A medicine that is potentially approved to treat one thing does not mean it is approved to treat other illnesses. https://www.reuters.com/article/factcheck-ivermectin-covid19/fact-check-website-does-not-prove-government-silently-approved-ivermectin-as-covid-19-treatment-idUSL1N2RN1TO. https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-09-03 16:11:25 UTC (1662221485585) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
0C91900F7892D8DA899BB85193A8758A | ||
2022-09-03 16:11:25 UTC (1662221485585) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 |
Note Ratings
rated at | rated by | |
2022-09-03 19:42:47 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
2022-09-05 05:01:30 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
2022-09-05 11:12:52 -0500 | 38F3548DB0968885447F4DB82116D4277DCAC84BCA00434FF4A2AF27332D007E | Rating Details |
2022-09-03 12:50:36 -0500 | 3C2E0B2AC0D0FE3C557514AC0255D80D | Rating Details |
2022-09-03 18:59:03 -0500 | 40625ACC55AFE31D886B21316D26C93A | Rating Details |
2022-09-03 20:08:52 -0500 | 46D893DFC474111C12B5EF54ADED5291021E07B5BC4D944EB4F35D18A93785C7 | Rating Details |
2022-09-03 13:34:29 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
2022-09-03 17:36:03 -0500 | 47CE75076B4EC5B451241F22FB56FBE6 | Rating Details |
2022-09-03 16:41:50 -0500 | 4B633FE63417FC95B913783E12D1B6AF | Rating Details |
2022-09-03 20:47:03 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
2022-09-03 12:14:03 -0500 | 5742EDEE3D0702801E8C42A693854A5C | Rating Details |
2022-09-04 21:15:01 -0500 | 58DCC3177CBF76252BC95E45E1CDCEDD949A78D0F82BD8178D49913D8726326B | Rating Details |
2022-09-03 20:47:03 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
2022-09-04 11:59:05 -0500 | 6C4D39819380C974F26A34B6C85405BD | Rating Details |
2022-09-04 19:17:37 -0500 | 71A49EE665957BB16D06E6E5008DA7ECF77E9835F05402A54A630965DD88545E | Rating Details |
2022-09-03 12:14:03 -0500 | 74C3CBB290F1DC31845CF3456C92E027F1E9028C50F938EB501A10342FF8150A | Rating Details |
2022-09-04 09:00:27 -0500 | 74E1E52EE8EB5E15EA1F55CF08E962E04EEFFEFB76C3E3817BF85EC664EB959B | Rating Details |
2022-09-03 12:36:01 -0500 | 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC | Rating Details |
2022-09-03 12:37:40 -0500 | 80B440D82AFDE0B37332323C1A5E2FE37D810CDCF0CC78D348D1E1237BA2CE8F | Rating Details |
2022-09-03 12:36:01 -0500 | 84656258148090979F23255CE507BE9C | Rating Details |
2022-09-03 12:37:40 -0500 | 8BFAD8285CAFFD31C0DBA633F2C52E42 | Rating Details |
2022-09-03 22:15:29 -0500 | 9439A1BE03E471B9F7026843AC7E7A4E | Rating Details |
2022-09-03 13:34:29 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
2022-09-04 11:59:05 -0500 | 9FDF9893DFAB4D45202E6558FAE3342DA24DFA5D58A9F7C14A2CF2DD79A3E176 | Rating Details |
2022-09-05 05:01:30 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
2022-09-03 19:42:47 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-09-03 17:36:03 -0500 | A8E19E20F2050BF3998242D88A5027E40DB258939006E09D57269202FD25B7CB | Rating Details |
2022-09-05 11:12:52 -0500 | AC5368A3F99A3EA105D5DE64E5F3BF1D | Rating Details |
2022-09-03 15:00:10 -0500 | AD8DC42A0C7729F56C4F30E56E6262C5285C3CADAB680599CAF1924DEA605484 | Rating Details |
2022-09-04 09:00:27 -0500 | AEFCDB949A0D44C0F7CFEB190DED5F1B | Rating Details |
2022-09-03 22:15:29 -0500 | B58FC591E8C96DE13676245FFD327D1A6F48B39F0D4D0298B1C0B07D02B268FD | Rating Details |
2022-09-03 16:41:50 -0500 | B81E5BB254A609770A08D4E04F69B8CB7C54F95A427285D9EE541F8FF802D29D | Rating Details |
2022-09-03 18:59:03 -0500 | C2C2E6523C841E4558B4DD193A51D198D6ADF28E86F47674D7FA108D07A1CE9E | Rating Details |
2022-09-04 21:15:01 -0500 | CD1F35016A8816108987739EEC9C84B9 | Rating Details |
2022-09-04 19:17:37 -0500 | D4E9594EC751DEEE7D67FE95734D9AD0 | Rating Details |
2022-09-03 20:08:52 -0500 | DB835EE09E208271F1AE42AA00D8490D | Rating Details |
2022-09-03 12:50:36 -0500 | DD2FFAAC440A7B50E636BD19FF1BF5EE43CFA9E35C5B9A25E77D957501E981BA | Rating Details |
2022-09-03 15:00:10 -0500 | DD716E5B0E50F0E1F626CD180E126B89 | Rating Details |
2022-09-03 20:08:52 -0500 | Rating Details | |
2022-09-03 16:41:50 -0500 | Rating Details | |
2022-09-03 22:15:29 -0500 | Rating Details | |
2022-09-04 19:17:37 -0500 | Rating Details | |
2022-09-05 05:01:30 -0500 | Rating Details | |
2022-09-03 19:42:47 -0500 | Rating Details | |
2022-09-03 12:37:40 -0500 | Rating Details | |
2022-09-03 12:14:03 -0500 | Rating Details | |
2022-09-05 11:12:52 -0500 | Rating Details | |
2022-09-04 11:59:05 -0500 | Rating Details | |
2022-09-04 09:00:27 -0500 | Rating Details | |
2022-09-03 15:00:10 -0500 | Rating Details | |
2022-09-03 17:36:03 -0500 | Rating Details | |
2022-09-03 20:47:03 -0500 | Rating Details | |
2022-09-03 18:59:03 -0500 | Rating Details | |
2022-09-03 12:50:36 -0500 | Rating Details | |
2022-09-03 13:34:29 -0500 | Rating Details | |
2022-09-03 12:36:01 -0500 | Rating Details |